Recent meta-analysis reported a statistically significant association between high Ki-67 expression and increased risk of breast cancer relapse and tumor-related death.29,19 It indicated that traditional bimolecular markers may not be an accurate prognostic factors for individual subtype, and further investigation is deemed necessary to be warranted. The gene discussed is MKI67; the disease is breast cancer.